Biolinx India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -36.22%
(FY 2023)
- Profit -63.04%
(FY 2023)
- Ebitda -48.38%
(FY 2023)
- Net Worth 32.47%
(FY 2023)
- Total Assets -16.63%
(FY 2023)
About Biolinx India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kizhakineth Nair and Rekha Nair serve as directors at the Company.
- CIN/LLPIN
U52399MH2012PTC229946
- Company No.
229946
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biolinx India Private Limited offer?
Biolinx India Private Limited offers a wide range of products and services, including Doors and Windows, Residential Door, Laboratory & Lab Equipment, Lab Accessories, Medical Laboratory Instruments, Hematology Analyzers, Autoclaves, Sterilizers & Incubators, Industrial Autoclave & Sterilizers.
Who are the key members and board of directors at Biolinx India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kizhakineth Nair  | Director | 19-Apr-2012 | Current |
| Rekha Nair | Director | 11-Feb-2013 | Current |
Financial Performance of Biolinx India.
Biolinx India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.22% decrease. The company also saw a substantial fall in profitability, with a 63.04% decrease in profit. The company's net worth Soared by an impressive increase of 32.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biolinx India?
In 2023, Biolinx India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inlabco Biosolutions Private LimitedActive 11 years 1 monthKizhakineth Nair and Rekha Nair are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biolinx India?
Unlock and access historical data on people associated with Biolinx India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biolinx India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolinx India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
